StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) stock

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

ADC Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

ADC Therapeutics's gross margin for the twelve months ending Dec 31, 2023 was 96.4%. For fiscal 2025 it was 92.9%, against 91.6% the year before. The highest annual figure on record is 100.0% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202592.9%+1.3
FY2024Dec 31, 202491.6%−4.8
FY2023Dec 31, 202396.4%−2.1
FY2022Dec 31, 202298.4%+2.5
FY2021Dec 31, 202195.9%−4.1
FY2019Dec 31, 2019100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2023Dec 31, 202398.5%−0.8
Q3 FY2023Sep 30, 202397.5%−0.8
Q2 FY2023Jun 30, 202393.2%+6.3
Q1 FY2023Mar 31, 202396.9%−2.0
Q4 FY2022Dec 31, 202299.3%+3.8
Q3 FY2022Sep 30, 202298.3%+2.1
Q2 FY2022Jun 30, 202286.9%−9.9
Q1 FY2022Mar 31, 202298.9%–
Q4 FY2021Dec 31, 202195.5%–
Q3 FY2021Sep 30, 202196.2%–
Q2 FY2021Jun 30, 202196.8%–

More ADC Therapeutics figures

See a number that looks wrong?